PhageLab stands at the forefront of the global battle against antibiotic resistance, offering a groundbreaking solution rooted in nature and augmented by cutting-edge technology.
Location: Chile, Santiago Metropolitan Region, Santiago
Total raised: $11M
Investors 3
| Date | Name | Website |
| 22.02.2024 | Nazca Vent... | nazca.vc |
| - | Humboldt | humboldtfu... |
| 04.01.2024 | Collab Fun... | collabfund... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.02.2024 | Series A | $11M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 02.02.2024 | Pitch Deck Teardown: PhageLab’s $11M Series A deck | As a species, we have a problem. Bacteria are becoming more and more resistant to antibiotics. Makes... | techcrunch... |
| 24.01.2024 | PhageLab Raises $11M in Funding | Hans Pieringer, Co-Founder and CEO, PhageLab PhageLab, a Santiago, Chile-based biotechnology company... | finsmes.co... |